Glycemic Control, Type II Diabetes, Parathyroidectomy
NCT05761743 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2026-05-26
Summary
The purpose of this study is to assess glycemic control after parathyroidectomy in patients with primary hyperparathyroidism and concomitant type 2 diabetes mellitus.
Conditions
- Primary Hyperparathyroidism
- Type 2 Diabetes
Interventions
- DIAGNOSTIC_TEST
-
Urine and Blood Test
Urine N-telopeptide and serum osteocalcin
Sponsors & Collaborators
-
The Cleveland Clinic
lead OTHER
Principal Investigators
-
Judy Jin, MD · The Cleveland Clinic
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-02-27
- Primary Completion
- 2025-12-31
- Completion
- 2026-08-01
Countries
- United States
Study Locations
More Related Trials
-
Blood Glucose Stability and Variability on Two Diets
NCT01443143 ·Status: UNKNOWN ·Phase: NA
-
2025 Hypoglycemia Early-Warning and Physician-Nurse Collaborative Management Trial in Type 2 Diabetes
NCT07314749 ·Status: COMPLETED ·Phase: NA
-
Effect of the Use of Continuous Glucose Monitoring Versus Standard Glycemic Control in Hospitalized Patients with Type 2 Diabetes.
NCT06607224 ·Status: COMPLETED ·Phase: NA
-
Establishing Ambulatory Glucose Profiles for People Without Diabetes Using CGM Data
NCT00467675 ·Status: COMPLETED
-
Feasibility and Effectiveness of Real-time, Remote Continuous Glucose Monitoring in Adolescents With Poorly Controlled Type 1 Diabetes
NCT04540536 ·Status: COMPLETED ·Phase: NA
-
Dexcom Continuous Glucose Monitoring in Long-term Care
NCT04818242 ·Status: COMPLETED ·Phase: NA
-
Observational Study to Evaluate the Effectiveness and Safety Study of the Dexcom G4™ Continuous Glucose Monitoring System
NCT01514305 ·Status: COMPLETED
-
Continuous Glucose Monitor Application After Hospital Discharge for the Improvement of Outcomes in Patients With Poorly Controlled Type 2 Diabetes and Active Cancer
NCT04938869 ·Status: COMPLETED ·Phase: NA
-
Continuous Glucose Monitoring to Reduce Hypoglycemia and Improve Safety After Gastric Surgery
NCT03353415 ·Status: COMPLETED ·Phase: NA
-
Glycemic Fluctuations in Newly Diagnosed Growth Hormone-Secreting Pituitary Adenoma and Cushing Syndrome Subjects
NCT02574793 ·Status: COMPLETED
-
Mechanisms of Hypoglycemia in Patients Without Diabetes
NCT04428723 ·Status: ACTIVE_NOT_RECRUITING
-
Incidence of Hypoglycaemia Events in Patients With Stable Insulin-treated Type 2 Diabetes Mellitus Based on Continuous Glucose Monitoring
NCT05461716 ·Status: UNKNOWN
-
Feasibility and Clinical Utility of the Dexcom G6 Continuous Glucose Monitoring Device for Type 2 Diabetes
NCT05523362 ·Status: COMPLETED ·Phase: NA
-
The Study to Investigate the Contribution of Basal and Postprandial Glucose to Overall Hyperglycemia in T2DM
NCT02648685 ·Status: COMPLETED
-
Inpatient Closed-loop Glucose Control
NCT01819844 ·Status: COMPLETED ·Phase: NA
-
Continuous Glucose Monitoring in Hospitalized Patients With Diabetes Mellitus
NCT04653454 ·Status: COMPLETED ·Phase: NA
-
Continuous Glucose Monitoring of Hospitalized Patients With Diabetes
NCT04230694 ·Status: COMPLETED ·Phase: NA
-
Effect of Fasting on Hypoglycemic Counterregulation in Type 1 Diabetes
NCT05973799 ·Status: RECRUITING ·Phase: NA
-
Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching
NCT05662462 ·Status: RECRUITING ·Phase: NA
-
Effect of Paired Testing to Poorly Controlled Chinese Diabetes on Glycemic Control and Self Care
NCT02225691 ·Status: UNKNOWN ·Phase: NA
-
Study to Prevent Dysglycemia in Women With GDM
NCT07269405 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes
NCT01341067 ·Status: COMPLETED
-
Inpatient Blood Glucose Control in Taichung Veterans General Hospital
NCT02885909 ·Status: RECRUITING ·Phase: PHASE4
-
Integrating the Use of Calibration-Free Continuous Monitoring for Pregnancy Glucose Profiling: I-Profile Study
NCT05123248 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Metformin in Achieving Glycaemia Goals as Recommended for the Treatment of Gestational Diabetes in Non Obese Women
NCT01756105 ·Status: TERMINATED ·Phase: PHASE2